Theragenics Corporation (TGX) - Financial and Strategic SWOT Analysis Review

Document Sample
Theragenics Corporation (TGX) - Financial and Strategic SWOT Analysis Review Powered By Docstoc
					       Theragenics Corporation (TGX) - Financial and Strategic SWOT Analysis
                                      Review
        Reference Code: GDME1246FSA                                                                                            Publication Date: JUL 2012

          5203 Bristol Industrial Way                        Phone              +1 770 2710233                  Revenue          82.7 (million USD)
          Buford, GA                                         Fax                +1 770 8315294                  Net Profit       3.06 (million USD)
          30518                                              Website            www.theragenics.com             Employees        500
                                                                                TGX [New York Stock
          United States                                      Exchange                                           Industry         Medical Equipment
                                                                                Exchange]

       Company Overview
       Theragenics Corporation (Theragenics) is a medical device company, which serves cancer treatment and surgical products
       markets. The company categorizes its business in two business segments, namely, Surgical Products business and
       Brachytherapy Seed business. It operates its Surgical Products business through its subsidiaries, CP Medical Corp., Galt Medical
       Corporation and NeedleTech Products, Inc. The Surgical Products business segment manufactures and distributes vascular
       access, wound closure and specialty needle products.
       Key Executives                                                                SWOT Analysis
                      Name                                 Title                      Theragenics Corporation, SWOT Analysis
         M. Christine Jacobs                 Chairman                                 Strengths                              Weaknesses
         John V. Herndon                     Director
                                                                                                                             Declining Liquidity Position
         Peter A.A. Saunders                 Director                                 Broad Product Portfolio
                                                                                                                             Concentrated Operations in the
         Kathleen A. Dahlberg                Director                                 Increased Profitability Ratios
                                                                                                                             US Region
         K. Wyatt Engwall                    Director
        Source: Annual Report, Company Website, Primary and Secondary
        Research, GlobalData                                                          Opportunities                          Threats

       Share Data                                                                     Strategic Alliances and                Rapid Technological Changes
         Theragenics Corporation                                                      Acquisitions
                                                                                                                             Use of Hazardous Materials
        Share Price (USD) as on 02-Jul-                                  1.98         Growing Aged Population
        2012
        EPS (USD)                                                        0.09
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
        Market Cap (million USD)                                           70        GlobalData

        Enterprise Value (million USD)                                     66
        Shares Outstanding (million)                                       35
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData

       Financial Performance                                                         Recent Developments
                                                                                      May 10, 2012         Theragenics Reports Revenue Of $21.6m In
                                                                                                           Q1 2012
                                                                                      May 03, 2012         Theragenics      Launches        Galt     Microslide
                                                                                                           Pediatric Introducer Line
                                                                                      Feb 23, 2012         Theragenics Reports Revenue Of $28.7m In
                                                                                                           2011
                                                                                      Nov 03, 2011         Theragenics Reports Revenues Of $21.1m In
                                                                                                           Q3 2011
                                                                                     Source: Annual Report, Company Website, Primary and Secondary Research,
                                                                                     GlobalData
       Source: Annual Report, Company Website, Primary and Secondary
       Research, GlobalData




Theragenics Corporation (TGX) - Financial and Strategic SWOT                                                                    Reference Code: GDME1246FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                     Page 1
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
       Table of Contents
       Table of Contents ............................................................................................................................................................................... 2
          List of Tables .................................................................................................................................................................................. 4
          List of Figures ................................................................................................................................................................................. 4
       Section 1 - About the Company.......................................................................................................................................................... 5
       Theragenics Corporation - Key Facts ................................................................................................................................................. 5
       Theragenics Corporation - Key Employees ........................................................................................................................................ 6
       Theragenics Corporation - Key Employee Biographies ...................................................................................................................... 7
       Theragenics Corporation - Major Products and Services ................................................................................................................... 8
       Theragenics Corporation - History .................................................................................................................................................... 11
       Theragenics Corporation - Company Statement .............................................................................................................................. 13
       Theragenics Corporation - Locations And Subsidiaries.................................................................................................................... 16
          Head Office ................................................................................................................................................................................... 16
       Theragenics Corporation - Key Manufacturing Facilities .................................................................................................................. 17
       Section 2 – Company Analysis ......................................................................................................................................................... 18
       Theragenics Corporation - Business Description ............................................................................................................................. 18
       Theragenics Corporation - Corporate Strategy................................................................................................................................. 19
       Theragenics Corporation - SWOT Analysis ...................................................................................................................................... 20
          SWOT Analysis - Overview........................................................................................................................................................... 20
          Theragenics Corporation - Strengths ............................................................................................................................................ 20
             Strength - Broad Product Portfolio ............................................................................................................................................ 20
             Strength - Increased Profitability Ratios .................................................................................................................................... 20
             Strength - Focused R&D Activities ............................................................................................................................................ 20
          Theragenics Corporation - Weaknesses ....................................................................................................................................... 21
             Weakness - Declining Liquidity Position .................................................................................................................................... 21
             Weakness - Concentrated Operations in the US Region .......................................................................................................... 21
             Weakness - Reliance on Distributors ........................................................................................................................................ 21
          Theragenics Corporation - Opportunities ...................................................................................................................................... 21
             Opportunity - Strategic Alliances and Acquisitions .................................................................................................................... 21
             Opportunity - Growing Aged Population .................................................................................................................................... 21
             Opportunity - Market Potential ................................................................................................................................................... 21
             Opportunity - Growing Oncology Market ................................................................................................................................... 22
          Theragenics Corporation - Threats ............................................................................................................................................... 22
             Threat - Rapid Technological Changes ..................................................................................................................................... 22
             Threat - Use of Hazardous Materials......................................................................................................................................... 22
             Threat - Competitive Landscape ............................................................................................................................................... 22
       Theragenics Corporation - Key Competitors .................................................................................................................................... 23
       Section 3 – Company Financial Ratios ............................................................................................................................................. 24
       Financial Ratios - Capital Market Ratios........................................................................................................................................... 24
       Financial Ratios - Annual Ratios ...................................................................................................................................................... 24
       Performance Chart ........................................................................................................................................................................... 26
       Financial Performance...................................................................................................................................................................... 26
       Financial Ratios - Interim Ratios....................................................................................................................................................... 27
       Financial Ratios - Ratio Charts ......................................................................................................................................................... 28
       Section 4 – Company’s Lifesciences Financial Deals and Alliances ................................................................................................ 29
          Theragenics Corporation, Medical Equipment, Deals By Year, 2006 to YTD 2012 ...................................................................... 29


Theragenics Corporation (TGX) - Financial and Strategic SWOT                                                                                                    Reference Code: GDME1246FSA
Analysis Review
Source : www.globalcompanyintelligence.com                                                                                                                                                                Page 2
© GlobalData. This report is a licensed product and is not to be copied, reproduced, shared or resold in any form
          Theragenics Corporation, Medical Equipment, Deals By Type, 2006 to YTD 2012 ............................................
				
DOCUMENT INFO
Description: Theragenics Corporation (Theragenics) is a medical device company, which serves cancer treatment and surgical products markets. The company categorizes its business in two business segments, namely, Surgical Products business and Brachytherapy Seed business. It operates its Surgical Products business through its subsidiaries, CP Medical Corp., Galt Medical Corporation and NeedleTech Products, Inc. The Surgical Products business segment manufactures and distributes vascular access, wound closure and specialty needle products.
BUY THIS DOCUMENT NOW PRICE: $125 100% MONEY BACK GUARANTEED
PARTNER GlobalData
GlobalData is an industry analysis specialist, providing business information products and services. GlobalData’s highly qualified team of analysts, researchers, and solution consultants use proprietary data sources, tools and techniques to gather, analyze and represent the latest and the most reliable information essential for a business to sustain a competitive edge. GlobalData is a UK-based company with presence across North America, Europe and Asia Pacific and has a broad product offering that ranges from interactive databases, reports and custom solutions. It is a comprehensive source of insights and analysis with coverage across the oil & gas, power, alternative energy, nuclear power, petrochemicals, medical equipment and healthcare industries. GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries. Sectors and Geographies Covered GlobalData has a broad range of coverage over key market segments. It has a global scope, covering a wide range of countries constituting more than 90% of global revenues in each of the industries it covers. Research Methodology With a large dedicated research and analysis capability, GlobalData employs rigorous primary and secondary research techniques in developing unique data sets and research materials. Its status as an independent research company allows Analysts to conduct trade interviews with key industry players. Access to unique databases of in-house market information further strengthens research and analysis capabilities. Materials are reviewed shaped by an expert panel of leading industry figures and representatives from key players in the relevant industries.